The molecular glue space has attracted several Big Pharma players over the past few years, including Novo Nordisk, Pfizer and ...
India's largest drugmaker by revenue Sun Pharmaceutical is aiming to launch its experimental anti-obesity and type 2 diabetes ...
Eli Lilly's bet on the Oscars shows the GLP-1 ad wars are heating up. - Eli Lilly. At the 2024 Academy Awards, Eli Lilly, the ...
Once again, Eli Lilly is using Hollywood’s biggest night as a platform to speak out on a hot-button issue in pharma. | Once ...
The life sciences industry experienced a dynamic year in 2024. As the public markets gained traction, IPO activity and venture investment saw ...
Eli Lilly is seeking to further cement its stance as a leader in weight loss drugs in an ad campaign calling out “unapproved” medications.
20h
Zacks.com on MSNPharma Stock Roundup: LLY Ups U.S. Manufacturing Investments & MoreEli Lilly LLY announced that it is increasing its manufacturing capacity in the United States by building four new plants.
Healthcare & Pharmaceuticalscategory Lilly plans to invest $27 billion in new US plants as Trump threatens pharmaceutical tariffs February 26, 2025 ...
Natco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 14,721.04 Crore) operating in Pharmaceuticals sector. Natco Pharma Ltd. key Products/Revenue Segments ...
Mankind Pharma Ltd., incorporated in the year 1991, is a Small Cap company (having a market cap of Rs 96,627.29 Crore) operating in Pharmaceuticals sector. Mankind Pharma Ltd. key Products/Revenue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results